Literature DB >> 23632100

The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.

Yuta Kono1, Kenji Tsushima, Koichi Yamaguchi, Nao Kurita, Seiko Soeda, Akahito Fujiwara, Shinya Sugiyama, Yuki Togashi, Satoshi Kasagi, Masako To, Yasuo To, Yasuhiro Setoguchi.   

Abstract

BACKGROUND: The diagnosis of pulmonary aspergillosis is difficult because the sensitivity of the conventional methods for the detection of Aspergillus such as culture and cytology, is poor. To improve the sensitivity for Aspergillus detection, the detection of galactomannan antigen has been investigated. The serum galactomannan (GM) antigen has been recognized to be a useful tool for the diagnosis of invasive pulmonary aspergillosis. However, the utility of the galactomannan antigen for the diagnosis of pulmonary aspergillosis other than invasive pulmonary aspergillosis (IPA) has been unclear.
METHODS: The GM antigen using serum and bronchial washing (BW) using bronchofiberscopy for the diagnosis of pulmonary aspergillosis other than IPA were measured.
RESULTS: In 45 enrolled patients, 7 patients had pulmonary aspergillosis, 5 of these patients had chronic necrotizing pulmonary aspergillosis and 2 patients had allergic bronchopulmonary aspergillosis. The area under the receiver operating characteristic (ROC) curve was 0.89 for the BW GM antigen detection test, and 0.41 for the serum GM antigen detection test, suggesting that the BW GM antigen detection test exhibits a better diagnostic performance than the serum GM antigen detection test. The BW GM antigen detection test had a sensitivity of 85.7% and a specificity of 76.3% at a cut-off level of ≥0.5, which was the optimal cut-off level obtained by the ROC curve.
CONCLUSION: The BW GM antigen detection test is thought to be a promising test for the diagnosis of pulmonary aspergillosis other than IPA.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23632100     DOI: 10.1016/j.rmed.2013.04.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  20 in total

1.  Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.

Authors:  Wei Zhou; Hongxing Li; Yan Zhang; Mei Huang; Qian He; Pei Li; Fang Zhang; Yi Shi; Xin Su
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Update on fungal diagnostics.

Authors:  Allen T Griffin; Kimberly E Hanson
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

3.  Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Naohisa Urabe; Susumu Sakamoto; Go Sano; Junko Suzuki; Akira Hebisawa; Yasuhiko Nakamura; Kazuya Koyama; Yoshikazu Ishii; Kazuhiro Tateda; Sakae Homma
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

4.  Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.

Authors:  G Cucchetto; A Cazzadori; M Conti; G L Cascio; P Braggio; E Concia
Journal:  Infection       Date:  2014-11-29       Impact factor: 3.553

5.  Subacute invasive pulmonary aspergillosis as a rare cause of pneumothorax in immunocompetent patient: brief report.

Authors:  Tatjana Adzic Vukicevic; Aleksandra Dudvarski-Ilic; Vladimir Zugic; Goran Stevanovic; Salvatore Rubino; Aleksandra Barac
Journal:  Infection       Date:  2017-02-23       Impact factor: 3.553

Review 6.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

7.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

8.  The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.

Authors:  Shuzhen Zhang; Sibu Wang; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

9.  Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies.

Authors:  Mahnaz Taremi; Michael E Kleinberg; Elizabeth W Wang; Bruce L Gilliam; Patrick A Ryscavage
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-11-14       Impact factor: 3.944

Review 10.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.